Biopsy Devices Market Outlook - 2026
The global biopsy devices market size was valued at $2,728 million in 2018 and is expected to reach $4,310 million by 2026, registering a CAGR of 5.9% during the forecast period.
Biopsy is a procedure to perform surgical removal of tissue from an organ to determine the presence or extent of a disease, generally cancerous and inflammatory conditions. It is generally performed by surgeons, radiologists, and interventional cardiologists. Biopsies can be performed on any organ using specific biopsy devices as a confirmatory test for cancer and celiac diseases. The usage of each biopsy device varies according to the type of organ under consideration. Conventional biopsy devices can be complemented with advanced imaging technologies, such as MRI-guided biopsy, stereotactic-guided biopsy, ultrasound-guided biopsy, CT scan, and others, to perform biopsy with accuracy and minimal invasiveness. These integrated procedures are used to perform biopsies on body organs such as the lungs, liver, and kidneys.
Significant increase in incidence of cancer, such as breast, prostate, and lung, and rapid technological advancements such as 3D optical biopsies, MRI-targeted biopsies, and Ultrasound–guided biopsies fuel the adoption of biopsy devices. Moreover, rise in awareness on diagnosis of chronic diseases fosters the demand for integrated biopsy technologies such as stereotactic-guided biopsy. However, high cost of biopsy devices and limited availability of skilled professionals in low income countries hinder the growth of the market.
Biopsy Devices Market Segmentation
The biopsy devices market is segmented on the basis of product, application, imaging technology, end user, and region. Based on product, the market is divided into needle-based biopsy instruments, biopsy forceps, localization wires, and other products. Based on application, the market is classified into breast biopsy, gastrointestinal (GI) biopsy, prostate biopsy, liver biopsy, lung biopsy, kidney biopsy, gynecological biopsy, and others. Based on imaging technology, the market is divided into MRI-guided biopsy, stereotactic-guided biopsy, ultrasound-guided biopsy, CT scan, and others. Based on end user, the market is categorized into diagnostic and imaging centers, hospitals, and others. Based on region, the biopsy devices market size is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Product segment review
By Product- Needle Based Biopsy Devices is projected as one of the most lucrative segments.
Based on product, the biopsy devices market is segmented into needle-based biopsy instruments, biopsy forceps, localization wires, and other products. The needle-based biopsy instruments acquired the largest biopsy devices market share in 2018. Furthermore, this segment is also expected to grow with fastest rate during the forecast period owing to increase in number of breast cancer, gastrointestinal tract diseases, and soft tissue sarcomas. Aspiration biopsy needles are non–invasive and provide efficient sample collection as compared to core biopsy devices, which require an incision. Furthermore, core biopsy devices are higher in cost as compared to vacuum-assisted biopsy devices and aspiration biopsy needles.
Application Segment review
According to application, the breast biopsy in the application segment generated the highest revenue in 2018 and is expected to maintain its dominance throughout the forecast period. This is attributed to an increase in the number of breast cancer patients that was witnessed over the years across the globe and is expected to maintain this trend in the future. Presently, breast cancer can be identified efficiently using advanced biopsy devices with higher efficiency in less time. In addition, increase in public awareness for disease screening, and technological advancement in biopsy devices has driven the demand for the use of biopsy devices worldwide.
By Imaging Technology- CT scan segment is projected as one of the most lucrative segments.
North America occupied the largest share of the market in 2018 and is expected to maintain its dominance during the forecast period owing to large availability of trained medical professionals, availability of well-developed infrastructure facilities, and presence of majority of key players. However, Asia-Pacific is expected to witness the highest growth rate throughout the forecast period, due to its high population base, surge in disposable income, and rise in patient awareness toward disease screening. In addition, increase in the geriatric population that is highly susceptible to cancer is the key contributor for the market growth in the region.
The major companies profiled in this report include Argon Medical Devices, Inc., B. Braun Melsungen AG, Becton Dickinson and Company (C.R. Bard, Inc.), Boston Scientific Corporation, Cardinal Health, Inc., Cook Medical, Inc., Danaher Corporation (Leica Microsystem), Fujifilm Holdings Corp., Hologic, Inc., and Medtronic plc.
By Region - Asia-Pacific region would exhibit the highest CAGR of 7.1% during 2019-2026.
Key Benefits for Biopsy Devices Market:
Biopsy Devices Market Segments:
By Product
By Application
By Imaging Technology
By End User
By Region
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. Key findings
2.2.1. Top investment pockets
2.3. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key Forces Shaping Biopsy Devices Industry/Market
3.2.1. High bargaining power of supplier
3.2.2. Moderate bargaining power of buyers
3.2.3. High threat of substitutes
3.2.4. Low threat of new entrant
3.2.5. Low intensity of rivalry
3.3. Market Share Analysis
3.4. Value chain analysis
3.5. Industry Pain point analysis
3.6. Market evolution/Industry roadmap
3.7. Regulatory norms
3.7.1. Regulatory issues of gastroenterology and urology biopsy devices in North America
3.7.2. Regulatory scenario for breast biopsy in European Union
3.8. Reimbursement scenario
3.8.1. Reimbursement for breast cancer screening in the U.S.
3.8.2. Reimbursement for breast reconstruction or prosthesis
3.9. Patent analysis
3.9.1. Patent analysis, by Country
3.9.2. Patent analysis, by Company
3.10. Case Studies
3.10.1. Case Study 01
3.10.2. Case Study 02
3.11. Market dynamics
3.11.1. Top impacting factors
3.11.2. Drivers
3.11.2.1. Significant increase in cancer incidence
3.11.2.2. Advent of novel and minimally invasive biopsy procedures
3.11.2.3. Increasing public awareness for disease screening
3.11.3. Restrains
3.11.3.1. Stiff competition from alternative cancer diagnostic tests
3.11.3.2. High cost and fluctuating reimbursement policies
3.11.4. Opportunities
3.11.4.1. Tapping diagnostic market present in emerging economies
CHAPTER 4: GLOBAL BIOPSY DEVICE MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Needle-based biopsy devices
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.2.4. Market size and forecast, by type
4.2.5. Core Biopsy Devices
4.2.5.1. Market size and forecast
4.2.6. Aspiration Biopsy Needles
4.2.6.1. Market size and forecast
4.2.7. Vacuum–assisted biopsy (VAB) devices
4.2.7.1. Market size and forecast
4.3. Biopsy forceps
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country
4.4. Localization Wires
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast
4.4.3. Market analysis, by country
4.5. Other Products
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast
4.5.3. Market analysis, by country
CHAPTER 5: GLOBAL BIOPSY DEVICES MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Breast biopsy
5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.3. Gastroenterology biopsy
5.3.1. Market size and forecast
5.3.2. Market analysis, by country
5.4. Prostate biopsy
5.4.1. Market size and forecast
5.4.2. Market analysis, by country
5.5. Liver biopsy
5.5.1. Market size and forecast
5.5.2. Market analysis, by country
5.6. Lung biopsy
5.6.1. Market size and forecast
5.6.2. Market analysis, by country
5.7. Kidney biopsy
5.7.1. Market size and forecast
5.7.2. Market analysis, by country
5.8. Gynaecological biopsy
5.8.1. Market size and forecast
5.8.2. Market analysis, by country
5.9. Others
5.9.1. Market size and forecast
5.9.2. Market analysis, by country
CHAPTER 6: GLOBAL BIOPSY DEVICE MARKET, BY IMAGING TECHNOLOGY
6.1. Overview
6.1.1. Market size and forecast
6.2. MRI–guided biopsy
6.2.1. Market size and forecast
6.2.2. Market analysis, by country
6.3. Stereotactic–guided biopsy
6.3.1. Market size and forecast
6.3.2. Market analysis, by country
6.4. Ultrasound–guided biopsy
6.4.1. Market size and forecast
6.4.2. Market analysis, by country
6.5. CT scan
6.5.1. Market size and forecast
6.5.2. Market analysis, by country
6.6. Others
6.6.1. Market size and forecast
6.6.2. Market analysis, by country
CHAPTER 7: GLOBAL BIOPSY DEVICES MARKET, BY END USERS
7.1. Overview
7.1.1. Market size and forecast
7.2. Diagnostic and Imaging Centers
7.2.1. Market size and forecast
7.2.2. Market analysis, by country
7.3. Hospitals
7.3.1. Market size and forecast
7.3.2. Market analysis, by country
7.4. Others
7.4.1. Market size and forecast
7.4.2. Market analysis, by country
CHAPTER 8: GLOBAL BIOPSY DEVICES MARKET BY REGION
8.1. Overview
8.1.1. Market size and forecast
8.2. North America
8.2.1. Key market trends, growth factors, and opportunities
8.2.2. Market size and forecast, by country
8.2.2.1. U.S.
8.2.2.1.1. U.S. biopsy devices market, by product
8.2.2.1.2. U.S. biopsy devices market, by application
8.2.2.1.3. U.S. biopsy devices market, by imaging technology
8.2.2.1.4. U.S. biopsy devices market, by end user
8.2.2.2. Canada
8.2.2.2.1. Canada biopsy devices market, by product
8.2.2.2.2. Canada biopsy devices market, by application
8.2.2.2.3. Canada biopsy devices market, by imaging technology
8.2.2.2.4. Canada biopsy devices market, by end user
8.2.2.3. Mexico
8.2.2.3.1. Mexico biopsy devices market, by product
8.2.2.3.2. Mexico biopsy devices market, by application
8.2.2.3.3. Mexico biopsy devices market, by imaging technology
8.2.2.3.4. Mexico biopsy devices market, by end user
8.2.3. North America market size and forecast, by product
8.2.4. North America market size and forecast, by application
8.2.5. North America market size and forecast, by imaging technology
8.2.6. North America market size and forecast, by end user
8.3. Europe
8.3.1. Key market trends, growth factors and opportunities
8.3.2. Market size and forecast, by country
8.3.2.1. UK
8.3.2.1.1. UK biopsy devices market, by product
8.3.2.1.2. UK biopsy devices market, by application
8.3.2.1.3. UK biopsy devices market, by imaging technology
8.3.2.1.4. UK biopsy devices market, by end user
8.3.2.2. Germany
8.3.2.2.1. Germany biopsy devices market, by product
8.3.2.2.2. Germany biopsy devices market, by application
8.3.2.2.3. Germany biopsy devices market, by imaging technology
8.3.2.2.4. Germany biopsy devices market, by end user
8.3.2.3. France
8.3.2.3.1. France biopsy devices market, by product
8.3.2.3.2. France biopsy devices market, by application
8.3.2.3.3. France biopsy devices market, by imaging technology
8.3.2.3.4. France biopsy devices market, by end user
8.3.2.4. Russia
8.3.2.4.1. Russia biopsy devices market, by product
8.3.2.4.2. Russia biopsy devices market, by application
8.3.2.4.3. Russia biopsy devices market, by imaging technology
8.3.2.4.4. Russia biopsy devices market, by end user
8.3.2.5. Spain
8.3.2.5.1. Spain biopsy devices market, by product
8.3.2.5.2. Spain biopsy devices market, by application
8.3.2.5.3. Spain biopsy devices market, by imaging technology
8.3.2.5.4. Spain biopsy devices market, by end user
8.3.2.6. Rest of Europe
8.3.2.6.1. Rest of Europe biopsy devices market, by product
8.3.2.6.2. Rest of Europe biopsy devices market, by application
8.3.2.6.3. Rest of Europe biopsy devices market, by imaging technology
8.3.2.6.4. Rest of Europe biopsy devices market, by end user
8.3.3. Europe market size and forecast, by product
8.3.4. Europe market size and forecast, by application
8.3.5. Europe market size and forecast, by imaging technology
8.3.6. Europe market size and forecast, by end user
8.4. Asia-Pacific
8.4.1. Key market trends, growth factors and opportunities
8.4.2. Market size and forecast, by country
8.4.2.1. China
8.4.2.1.1. China biopsy devices market, by product
8.4.2.1.2. China biopsy devices market, by application
8.4.2.1.3. China biopsy devices market, by imaging technology
8.4.2.1.4. China biopsy devices market, by end user
8.4.2.2. India
8.4.2.2.1. India biopsy devices market, by product
8.4.2.2.2. India biopsy devices market, by application
8.4.2.2.3. India biopsy devices market, by imaging technology
8.4.2.2.4. India biopsy devices market, by end user
8.4.2.3. Japan
8.4.2.3.1. Japan biopsy devices market, by product
8.4.2.3.2. Japan biopsy devices market, by application
8.4.2.3.3. Japan biopsy devices market, by imaging technology
8.4.2.3.4. Japan biopsy devices market, by end user
8.4.2.4. Australia
8.4.2.4.1. Australia biopsy devices market, by product
8.4.2.4.2. Australia biopsy devices market, by application
8.4.2.4.3. Australia biopsy devices market, by imaging technology
8.4.2.4.4. Australia biopsy devices market, by end user
8.4.2.5. South Korea
8.4.2.5.1. South Korea biopsy devices market, by product
8.4.2.5.2. South Korea biopsy devices market, by application
8.4.2.5.3. South Korea biopsy devices market, by imaging technology
8.4.2.5.4. South Korea biopsy devices market, by end user
8.4.2.6. Rest of Asia-Pacific
8.4.2.6.1. Rest of Asia-Pacific biopsy devices market, by product
8.4.2.6.2. Rest of Asia-Pacific biopsy devices market, by application
8.4.2.6.3. Rest of Asia-Pacific biopsy devices market, by imaging technology
8.4.2.6.4. Rest of Asia-Pacific biopsy devices market, by end user
8.4.3. Asia-Pacific market size and forecast, by product
8.4.4. Asia-Pacific market size and forecast, by application
8.4.5. Asia-Pacific market size and forecast, by imaging technology
8.4.6. Asia-Pacific market size and forecast, by end user
8.5. LAMEA
8.5.1. Key market trends, growth factors and opportunities
8.5.2. Market size and forecast, by country
8.5.2.1. Brazil
8.5.2.1.1. Brazil biopsy devices market, by product
8.5.2.1.2. Brazil biopsy devices market, by application
8.5.2.1.3. Brazil biopsy devices market, by imaging technology
8.5.2.1.4. Brazil biopsy devices market, by end user
8.5.2.2. Saudi Arabia
8.5.2.2.1. Saudi Arabia biopsy devices market, by product
8.5.2.2.2. Saudi Arabia biopsy devices market, by application
8.5.2.2.3. Saudi Arabia biopsy devices market, by imaging technology
8.5.2.2.4. Saudi Arabia biopsy devices market, by end user
8.5.2.3. South Africa
8.5.2.3.1. South Africa biopsy devices market, by product
8.5.2.3.2. South Africa biopsy devices market, by application
8.5.2.3.3. South Africa biopsy devices market, by imaging technology
8.5.2.3.4. South Africa biopsy devices market, by end user
8.5.2.4. Rest of LAMEA
8.5.2.4.1. Rest of LAMEA biopsy devices market, by product
8.5.2.4.2. Rest of LAMEA biopsy devices market, by application
8.5.2.4.3. Rest of LAMEA biopsy devices market, by imaging technology
8.5.2.4.4. Rest of LAMEA biopsy devices market, by end user
8.5.3. LAMEA market size and forecast, by product
8.5.4. LAMEA market size and forecast, by application
8.5.5. LAMEA market size and forecast, by imaging technology
8.5.6. LAMEA market size and forecast, by end user
CHAPTER 9: COMPETITIVE LANDSCAPE
9.1. Competitive heatmap
CHAPTER 10: COMPANY PROFILES
10.1. Argon Medical Devices, Inc.
10.1.1. Company overview
10.1.2. Company snapshot
10.1.3. Operating business segments
10.1.4. Product portfolio
10.2. B Braun Melsungen AG
10.2.1. Company overview
10.2.2. Company snapshot
10.2.3. Operating business segments
10.2.4. Product portfolio
10.2.5. Business performance
10.3. Becton Dickinson and Company (C. R. Bard, Inc.)
10.3.1. Company overview
10.3.2. Company snapshot
10.3.3. Operating business segments
10.3.4. Product portfolio
10.3.5. Business performance
10.4. Boston Scientific Corporation
10.4.1. Company overview
10.4.2. Company snapshot
10.4.3. Operating business segments
10.4.4. Product portfolio
10.4.5. Business performance
10.4.6. Key strategic moves and developments
10.5. Cardinal Health, Inc.
10.5.1. Company overview
10.5.2. Company snapshot
10.5.3. Operating business segments
10.5.4. Product portfolio
10.5.5. Business performance
10.6. Cook Medical, Inc.
10.6.1. Company overview
10.6.2. Company snapshot
10.6.3. Operating business segments
10.6.4. Product portfolio
10.6.5. Key strategic moves and developments
10.7. Danaher Corporation (Leica Microsystem)
10.7.1. Company overview
10.7.2. Company snapshot
10.7.3. Operating business segments
10.7.4. Product portfolio
10.7.5. Business performance
10.8. Fujifilm Holdings Corp.
10.8.1. Company overview
10.8.2. Company snapshot
10.8.3. Operating business segments
10.8.4. Product portfolio
10.8.5. Business performance
10.8.6. Key strategic moves and developments
10.9. Hologic, Inc.
10.9.1. Company overview
10.9.2. Company snapshot
10.9.3. Operating business segments
10.9.4. Product portfolio
10.9.5. Business performance
10.9.6. Key strategic moves and developments
10.10. Medtronic Plc.
10.10.1. Company overview
10.10.2. Company snapshot
10.10.3. Operating business segments
10.10.4. Product portfolio
10.10.5. Business performance
LIST OF TABLES
TABLE 01. GLOBAL BIOPSY DEVICES MARKET, BY PRODUCT, 2018 – 2026 ($MILLION)
TABLE 02. NEEDLE-BASED BIOPSY DEVICES MARKET, BY REGION, 2018-2026, ($MILLION)
TABLE 03. NEEDLE-BASED BIOPSY DEVICES MARKET, BY TYPE, 2018-2026, ($MILLION)
TABLE 04. BIOPSY FORCEPS MARKET, BY REGION, 2018 – 2026 ($MILLION)
TABLE 05. LOCALIZATION WIRES BIOPSY DEVICES MARKET, BY REGION, 2018 – 2026 ($MILLION)
TABLE 06. OTHER PRODUCTS BIOPSY DEVICES MARKET BY REGION, 2018 – 2026 ($MILLION)
TABLE 07. GLOBAL BIOPSY DEVICES MARKET, BY APPLICATION, 2018 – 2026 ($MILLION)
TABLE 08. BREAST BIOPSY DEVICES MARKET, BY REGION, 2018 – 2026($MILLION)
TABLE 09. GASTROENTEROLOGY BIOPSY DEVICES MARKET, BY REGION, 2018 – 2026 ($MILLION)
TABLE 10. PROSTATE BIOPSY DEVICES MARKET, BY REGION, 2018 – 2026 ($MILLION)
TABLE 11. LIVER BIOPSY DEVICES MARKET, BY REGION, 2018 – 2026 ($MILLION)
TABLE 12. LUNG GLOBAL BIOPSY DEVICES MARKET, BY REGION, 2018 – 2026 ($MILLION)
TABLE 13. KIDNEY BIOPSY DEVICES MARKET, BY REGION, 2018 – 2026 ($MILLION)
TABLE 14. GYNAECOLOGICAL BIOPSY DEVICES MARKET, BY REGION, 2018 – 2026 ($MILLION)
TABLE 15. OTHERS BIOPSY DEVICES MARKET, BY REGION, 2018 – 2026 ($MILLION)
TABLE 16. GLOBAL BIOPSY DEVICE MARKET, BY IMAGE GUIDED TECHNOLOGY, 2018 – 2026 ($MILLION)
TABLE 17. MRI GUIDED BIOPSY DEVICES MARKET, BY REGION, 2018 – 2026 ($MILLION)
TABLE 18. STEREOTACTIC-GUIDED BIOPSY DEVICES MARKET, BY REGION, 2018 – 2026 ($MILLION)
TABLE 19. ULTRASOUND GUIDED BIOPSY DEVICES MARKET, BY REGION, 2018 – 2026 ($MILLION)
TABLE 20. CT SCAN BIOPSY DEVICES MARKET, BY REGION, 2018 – 2026 ($MILLION)
TABLE 21. OTHERS IMAGE GUIDED BIOPSY DEVICES MARKET, BY REGION, 2018 – 2026 ($MILLION)
TABLE 22. GLOBAL BIOPSY DEVICES MARKET, BY END USERS, 2018 – 2026 ($MILLION)
TABLE 23. DIAGNOSTIC AND IMAGING CENTERS BIOPSY DEVICES MARKET, BY REGION, 2018 – 2026, ($MILLION)
TABLE 24. BIOPSY DEVICES MARKET FOR HOSPITALS, BY REGION, 2018 – 2026, ($MILLION)
TABLE 25. OTHERS BIOPSY DEVICES MARKET, BY REGION, 2018 – 2026, ($MILLION)
TABLE 26. GLOBAL BIOPSY DEVICE MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 27. NORTH AMERICA BIOPSY DEVICES MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 28. U.S. BIOPSY DEVICES MARKET, BY PRODUCT, 2018–2026
TABLE 29. U.S. BIOPSY DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 30. U.S. BIOPSY DEVICES MARKET, BY IMAGING TECHNOLOGY, 2018–2026
TABLE 31. U.S. BIOPSY DEVICES MARKET, BY END USER, 2018–2026
TABLE 32. CANADA BIOPSY DEVICES MARKET, BY PRODUCT, 2018–2026
TABLE 33. CANADA BIOPSY DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 34. CANADA BIOPSY DEVICES MARKET, BY IMAGING TECHNOLOGY, 2018–2026
TABLE 35. CANADA BIOPSY DEVICES MARKET, BY END USER, 2018–2026
TABLE 36. MEXICO BIOPSY DEVICES MARKET, BY PRODUCT, 2018–2026
TABLE 37. MEXICO BIOPSY DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 38. MEXICO BIOPSY DEVICES MARKET, BY IMAGING TECHNOLOGY, 2018–2026
TABLE 39. MEXICO BIOPSY DEVICES MARKET, BY END USER, 2018–2026
TABLE 40. NORTH AMERICA BIOPSY DEVICES MARKET, BY PRODUCT, 2018–2026
TABLE 41. NORTH AMERICA BIOPSY DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 42. NORTH AMERICA BIOPSY DEVICES MARKET, BY IMAGING TECHNOLOGY, 2018–2026
TABLE 43. NORTH AMERICA BIOPSY DEVICES MARKET, BY END USER, 2018–2026
TABLE 44. EUROPE BIOPSY DEVICES MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 45. UK BIOPSY DEVICES MARKET, BY PRODUCT, 2018–2026
TABLE 46. UK BIOPSY DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 47. UK BIOPSY DEVICES MARKET, BY IMAGING TECHNOLOGY, 2018–2026
TABLE 48. UK BIOPSY DEVICES MARKET, BY END USER, 2018–2026
TABLE 49. GERMANY BIOPSY DEVICES MARKET, BY PRODUCT, 2018–2026
TABLE 50. GERMANY BIOPSY DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 51. GERMANY BIOPSY DEVICES MARKET, BY IMAGING TECHNOLOGY, 2018–2026
TABLE 52. GERMANY BIOPSY DEVICES MARKET, BY END USER, 2018–2026
TABLE 53. FRANCE BIOPSY DEVICES MARKET, BY PRODUCT, 2018–2026
TABLE 54. FRANCE BIOPSY DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 55. FRANCE BIOPSY DEVICES MARKET, BY IMAGING TECHNOLOGY, 2018–2026
TABLE 56. FRANCE BIOPSY DEVICES MARKET, BY END USER, 2018–2026
TABLE 57. RUSSIA BIOPSY DEVICES MARKET, BY PRODUCT, 2018–2026
TABLE 58. RUSSIA BIOPSY DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 59. RUSSIA BIOPSY DEVICES MARKET, BY IMAGING TECHNOLOGY, 2018–2026
TABLE 60. RUSSIA BIOPSY DEVICES MARKET, BY END USER, 2018–2026
TABLE 61. SPAIN BIOPSY DEVICES MARKET, BY PRODUCT, 2018–2026
TABLE 62. SPAIN BIOPSY DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 63. SPAIN BIOPSY DEVICES MARKET, BY IMAGING TECHNOLOGY, 2018–2026
TABLE 64. SPAIN BIOPSY DEVICES MARKET, BY END USER, 2018–2026
TABLE 65. REST OF EUROPE BIOPSY DEVICES MARKET, BY PRODUCT, 2018–2026
TABLE 66. REST OF EUROPE BIOPSY DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 67. REST OF EUROPE BIOPSY DEVICES MARKET, BY IMAGING TECHNOLOGY, 2018–2026
TABLE 68. REST OF EUROPE BIOPSY DEVICES MARKET, BY END USER, 2018–2026
TABLE 69. EUROPE BIOPSY DEVICES MARKET, BY PRODUCT, 2018–2026
TABLE 70. EUROPE BIOPSY DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 71. EUROPE BIOPSY DEVICES MARKET, BY IMAGING TECHNOLOGY, 2018–2026
TABLE 72. EUROPE BIOPSY DEVICES MARKET, BY END USER, 2018–2026
TABLE 73. ASIA-PACIFIC BIOPSY DEVICES MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 74. CHINA BIOPSY DEVICES MARKET, BY PRODUCT, 2018–2026
TABLE 75. CHINA BIOPSY DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 76. CHINA BIOPSY DEVICES MARKET, BY IMAGING TECHNOLOGY, 2018–2026
TABLE 77. CHINA BIOPSY DEVICES MARKET, BY END USER, 2018–2026
TABLE 78. INDIA BIOPSY DEVICES MARKET, BY PRODUCT, 2018–2026
TABLE 79. INDIA BIOPSY DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 80. INDIA BIOPSY DEVICES MARKET, BY IMAGING TECHNOLOGY, 2018–2026
TABLE 81. INDIA BIOPSY DEVICES MARKET, BY END USER, 2018–2026
TABLE 82. JAPAN BIOPSY DEVICES MARKET, BY PRODUCT, 2018–2026
TABLE 83. JAPAN BIOPSY DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 84. JAPAN BIOPSY DEVICES MARKET, BY IMAGING TECHNOLOGY, 2018–2026
TABLE 85. JAPAN BIOPSY DEVICES MARKET, BY END USER, 2018–2026
TABLE 86. AUSTRALIA BIOPSY DEVICES MARKET, BY PRODUCT, 2018–2026
TABLE 87. AUSTRALIA BIOPSY DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 88. AUSTRALIA BIOPSY DEVICES MARKET, BY IMAGING TECHNOLOGY, 2018–2026
TABLE 89. AUSTRALIA BIOPSY DEVICES MARKET, BY END USER, 2018–2026
TABLE 90. SOUTH KOREA BIOPSY DEVICES MARKET, BY PRODUCT, 2018–2026
TABLE 91. SOUTH KOREA BIOPSY DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 92. SOUTH KOREA BIOPSY DEVICES MARKET, BY IMAGING TECHNOLOGY, 2018–2026
TABLE 93. SOUTH KOREA BIOPSY DEVICES MARKET, BY END USER, 2018–2026
TABLE 94. REST OF ASIA-PACIFIC BIOPSY DEVICES MARKET, BY PRODUCT, 2018–2026
TABLE 95. REST OF ASIA-PACIFIC BIOPSY DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 96. REST OF ASIA-PACIFIC BIOPSY DEVICES MARKET, BY IMAGING TECHNOLOGY, 2018–2026
TABLE 97. REST OF ASIA-PACIFIC BIOPSY DEVICES MARKET, BY END USER, 2018–2026
TABLE 98. ASIA-PACIFIC BIOPSY DEVICES MARKET, BY PRODUCT, 2018–2026
TABLE 99. ASIA-PACIFIC BIOPSY DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 100. ASIA-PACIFIC BIOPSY DEVICES MARKET, BY IMAGING TECHNOLOGY, 2018–2026
TABLE 101. ASIA-PACIFIC BIOPSY DEVICES MARKET, BY END USER, 2018–2026
TABLE 102. LAMEA BIOPSY DEVICES MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 103. BRAZIL BIOPSY DEVICES MARKET, BY PRODUCT, 2018–2026
TABLE 104. BRAZIL BIOPSY DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 105. BRAZIL BIOPSY DEVICES MARKET, BY IMAGING TECHNOLOGY, 2018–2026
TABLE 106. BRAZIL BIOPSY DEVICES MARKET, BY END USER, 2018–2026
TABLE 107. SAUDI ARABIA BIOPSY DEVICES MARKET, BY PRODUCT, 2018–2026
TABLE 108. SAUDI ARABIA BIOPSY DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 109. SAUDI ARABIA BIOPSY DEVICES MARKET, BY IMAGING TECHNOLOGY, 2018–2026
TABLE 110. SAUDI ARABIA BIOPSY DEVICES MARKET, BY END USER, 2018–2026
TABLE 111. SOUTH AFRICA BIOPSY DEVICES MARKET, BY PRODUCT, 2018–2026
TABLE 112. SOUTH AFRICA BIOPSY DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 113. SOUTH AFRICA BIOPSY DEVICES MARKET, BY IMAGING TECHNOLOGY, 2018–2026
TABLE 114. SOUTH AFRICA BIOPSY DEVICES MARKET, BY END USER, 2018–2026
TABLE 115. REST OF LAMEA BIOPSY DEVICES MARKET, BY PRODUCT, 2018–2026
TABLE 116. REST OF LAMEA BIOPSY DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 117. REST OF LAMEA BIOPSY DEVICES MARKET, BY IMAGING TECHNOLOGY, 2018–2026
TABLE 118. REST OF LAMEA BIOPSY DEVICES MARKET, BY END USER, 2018–2026
TABLE 119. LAMEA BIOPSY DEVICES MARKET, BY PRODUCT, 2018–2026
TABLE 120. LAMEA BIOPSY DEVICES MARKET, BY APPLICATION, 2018–2026
TABLE 121. LAMEA BIOPSY DEVICES MARKET, BY IMAGING TECHNOLOGY, 2018–2026
TABLE 122. LAMEA BIOPSY DEVICES MARKET, BY END USER, 2018–2026
TABLE 123. COMPETITIVE HEATMAP OF KEY PLAYERS
TABLE 124. COMPETITIVE HEATMAP OF OTHER PLAYERS
TABLE 125. ARGON MEDICAL DEVICES: COMPANY SNAPSHOT
TABLE 126. ARGON MEDICAL DEVICES: PRODUCT PORTFOLIO
TABLE 127. B BRAUN: COMPANY SNAPSHOT
TABLE 128. B BRAUN: OPERATING SEGMENTS
TABLE 129. B BRAUN: PRODUCT PORTFOLIO
TABLE 130. BD: COMPANY SNAPSHOT
TABLE 131. BD: OPERATING SEGMENTS
TABLE 132. BD: PRODUCT PORTFOLIO
TABLE 133. BOSTON SCIENTIFIC: COMPANY SNAPSHOT
TABLE 134. BOSTON SCIENTIFIC: OPERATING SEGMENTS
TABLE 135. BOSTON SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 136. CARDINAL HEALTH: COMPANY SNAPSHOT
TABLE 137. CARDINAL HEALTH: OPERATING SEGMENTS
TABLE 138. CARDINAL HEALTH: PRODUCT PORTFOLIO
TABLE 139. COOK MEDICAL: COMPANY SNAPSHOT
TABLE 140. COOK MEDICAL: OPERATING SEGMENTS
TABLE 141. COOK MEDICAL: PRODUCT PORTFOLIO
TABLE 142. DANAHER: COMPANY SNAPSHOT
TABLE 143. DANAHER: OPERATING SEGMENTS
TABLE 144. DANAHER: PRODUCT PORTFOLIO
TABLE 145. FUJIFILM: COMPANY SNAPSHOT
TABLE 146. FUJIFILM: OPERATING SEGMENTS
TABLE 147. FUJIFILM: PRODUCT PORTFOLIO
TABLE 148. HOLOGIC: COMPANY SNAPSHOT
TABLE 149. HOLOGIC: OPERATING SEGMENTS
TABLE 150. HOLOGIC: PRODUCT PORTFOLIO
TABLE 151. MEDTRONIC: COMPANY SNAPSHOT
TABLE 152. MEDTRONIC: OPERATING SEGMENTS
TABLE 153. MEDTRONIC: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01. COMPARATIVE ANALYSIS OF NEEDLE-BASED BIOPSY DEVICES MARKET, BY COUNTRY,2018 & 2026 ($MILLION)
FIGURE 02. CORE BIOPSY NEEDLE MARKET, 2018–2026 ($MILLION)
FIGURE 03. ASPIRATION BIOPSY NEEDLE MARKET, 2018–2026 ($MILLION)
FIGURE 04. VACUUM–ASSISTED BIOPSY (VAB) NEEDLE MARKET, 2018–2026 ($MILLION)
FIGURE 05. COMPARATIVE ANALYSIS OF BIOPSY FORCEPS MARKET, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 06. COMPARATIVE ANALYSIS OF LOCALIZATION WIRES MARKET, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 07. COMPARATIVE ANALYSIS OF OTHER PRODUCTS MARKET, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 08. COMPARATIVE ANALYSIS OF BREAST BIOPSY DEVICES MARKET, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 09. COMPARATIVE ANALYSIS OF GASTROENTEROLOGY BIOPSY DEVICES MARKET, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 10. COMPARATIVE ANALYSIS OF PROSTATE BIOPSY DEVICES MARKET, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 11. COMPARATIVE ANALYSIS OF LIVER BIOPSY DEVICES MARKET, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 12. COMPARATIVE ANALYSIS OF LUNG BIOPSY DEVICES MARKET, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 13. COMPARATIVE ANALYSIS OF KIDNEY BIOPSY DEVICES MARKET, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 14. COMPARATIVE ANALYSIS OF GYNECOLOGICAL BIOPSY DEVICES MARKET, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 15. COMPARATIVE ANALYSIS OF OTHERS BIOPSY DEVICES MARKET, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 16. COMPARATIVE ANALYSIS OF MRI GUIDED BIOPSY DEVICES MARKET, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 17. COMPARATIVE ANALYSIS OF STEREOTACTIC-GUIDED BIOPSY DEVICES MARKET, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 18. COMPARATIVE ANALYSIS OF ULTRASOUND GUIDED BIOPSY DEVICES MARKET, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 19. COMPARATIVE ANALYSIS OF CT SCAN BIOPSY DEVICES MARKET, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 20. COMPARATIVE ANALYSIS OF OTHERS IMAGE GUIDED BIOPSY DEVICES MARKET, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 21. COMPARATIVE ANALYSIS OF DIAGNOSTIC AND IMAGING CENTERS BIOPSY DEVICES MARKET, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 22. COMPARATIVE ANALYSIS OF BIOPSY DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2018 & 2026 ($MILLION)
FIGURE 23. COMPARATIVE ANALYSIS OF OTHERS BIOPSY DEVICES MARKET, BY COUNTRY, 2018 & 2026 ($MILLION)
$5540
$6654
$9280
Add to Cart
Add to Cart
Add to Cart
Add to Cart